𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytochrome c: a non-invasive biomarker of drug-induced liver injury

✍ Scribed by T. J. Miller; A. Knapton; O. Adeyemo; L. Noory; J. Weaver; J. P. Hanig

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
507 KB
Volume
28
Category
Article
ISSN
0260-437X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Limitations of existing biomarkers to detect liver injury in experimental animals highlight the need for additional tools to predict human toxicity. The utility of cytochrome c (cyt c) as a biomarker in serum and urine was evaluated in two rodent liver injury models. Adult Sprague–Dawley rats treated with acetaminophen or d‐galactosamine (GalN) showed dose‐ and time‐dependent histomorphological changes and TUNEL staining in liver consistent with hepatocellular necrosis, apoptosis and inflammation up to 72 h. Matching changes in serum alanine transaminase (ALT), aspartate transaminase (AST) and cyt c peaked at 24 h for either drug at the highest dose, cyt c falling rapidly at 48 hours with ALT and AST remained high. Intracellular transit of cyt c from mitochondria to the cytoplasm in damaged hepatocytes, and then to peripheral circulation, was observed by immunohistochemistry. Correlation coefficients between cyt c and serum diagnostic tests indicate the liver to be the primary source of cyt c. Urinary analysis for cyt c revealed time‐dependent increase at 6 h, peaking at 24 h in GalN‐treated rats in contrast with irregular patterns of urinary ALT and AST activity. Histological changes detected at 6 h preceded altered ALT, AST and cyt c at 12 and 18 h, respectively, in GalN‐treated rats. These studies demonstrate cyt c to be a useful indicator of hepatic injury in rodents and support its utility as a non‐invasive predictor of drug‐induced hepatotoxicity, when utilized as a potential urinary biomarker. Published in 2008 by John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Pharmacogenetics of drug-induced liver i
Pharmacogenetics of drug-induced liver injury
✍ Stefan Russmann; Alexander Jetter; Gerd A. Kullak-Ublick 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Recent progress in research on drug-induced liver injury (DILI) has been determined by key developments in two areas. First, new technologies allow the identification of genetic risk factors with improved sensitivity, specificity, and efficiency. Second, new mechanistic concepts of DILI emphasize th

Drug-induced liver injury: Summary of a
Drug-induced liver injury: Summary of a single topic clinical research conference
✍ Paul B. Watkins; Leonard B. Seeff 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

Idiosyncratic drug induced liver injury (DILI) remains poorly understood. It is assumed that the affected individuals possess a rare combination of genetic and non genetic factors that, if identified, would greatly improve understanding of the underlying mechanisms. This single topic conference brou

The use of liver biopsy evaluation in di
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury
✍ Ayako Suzuki; Elizabeth M. Brunt; David E. Kleiner; Rosa Miquel; Thomas C. Smyrk 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 598 KB

Distinguishing drug-induced liver injury (DILI) from idiopathic autoimmune hepatitis (AIH) can be challenging. We performed a standardized histologic evaluation to explore potential hallmarks to differentiate AIH versus DILI. Biopsies from patients with clinically well-characterized DILI [n = 35, in

Outcome of acute idiosyncratic drug-indu
Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry
✍ Raúl J. Andrade; M. Isabel Lucena; Neil Kaplowitz; Beatriz García-Muņoz; Yolanda 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

A chronic adverse reaction may occur in some instances of drug-induced liver injury (DILI), even despite drug cessation. In our study, we obtained records from a Spanish registry and evaluated cases of DILI with biochemical evidence of long-term damage. Chronic outcome was defined as a persistent bi

Standardization of nomenclature and caus
Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshop
✍ Robert J. Fontana; Leonard B. Seeff; Raúl J. Andrade; Einar Björnsson; Christoph 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

Idiosyncratic drug-induced liver injury (DILI) is an important but relatively infrequent cause of potentially severe acute and chronic liver injury. The aim of this clinical research workshop was to review and attempt to standardize the current nomenclature and terminology used in DILI research. Bec